Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal hematopoiesis in Philadelphia chromosome-negative bone marrow cells of chronic myeloid leukemia patients receiving tyrosine kinase inhibitors
    Meeting Abstract

    Paquette, R.; Nicoll, J.; Chalukya, M.; Gondek, L. P.; Jasek, M.; Sawyers, C.; Shah, N.; Maciejewski, J.
    Blood (2008)

    Fulltext@MSK | Save
  • MicroRNA regulation directs lineage- and developmental stage-specific transgene expression in hematopoietic stem cell progeny
    Meeting Abstract

    Papapetrou, E.; Kovalovsky, D.; Beloeil, L.; Sant'angelo, D.; Sadelain, M.
    Blood Cells, Molecules, and Diseases (2008)

    Fulltext@MSK | Save
  • Effect of peri-transplant Linezolid on time to neutrophil and platelet engraftment after allogeneic stem cell transplantation (HSCT)
    Meeting Abstract

    Papanicolaou, G. A.; Cohen, N.; Mihu, C.; Jakubowski, A.; Pamer, E.; Chou, J.; Heller, G.
    International Journal of Infectious Diseases (2008)

    Fulltext@MSK | Save
  • Signal transduction in chronic lymphocytic leukemia (CLL) cells by multiparameter flow-cytometry
    Meeting Abstract

    Palomba, M. L.; Patel, J. P.; Rao, U.; Rastalsky, N.; Lu, S. X.; Houghton, A. N.; Zelenetz, A. D.; Van Den Brink, M. R.
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Use of the tetanus toxoid, reduced dose diphtheria and pertussis vaccine (Tdap) in allogeneic transplant (alloHCT) recipients
    Meeting Abstract

    Papadopoulos, E. B.; Young, J. W.; Kernan, N. A.; Boulad, F.; Castro-Malaspina, H. R.; O'Reilly, R. J.; Prockop, S.; Scaradavou, A.; Taylor, J.; Ford, R.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • PROPEL: A multi-center phase 2 open-label study of pralatrexate (PDX) with vitamin B(12) and folic acid supplementation in patients with replapsed or refractory peripheral T-cell lymphoma
    Meeting Abstract

    O'Connor, O. A.; Pro, B.; Pinter-Brown, L.; Popplewell, L.; Barlett, N.; Shustov, A.; Lechowicz, M. J.; Savage, K. J.; Coiffier, B.; Jacobsen, E.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • A phase 1 study evaluating the safety, PK & efficacy of ABT-263 in subjects with refractory or relapsed lymphoid malignancies
    Meeting Abstract

    O'connor, O.; Czuczman, M. S.; LaCasce, A.; Gerecitano, J.; Leonard, J. P.; Dunleavy, K.; Krivoshik, A.; Shovlin, M.; Narwal, A.; Xiong, H.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • Pralatrexate (PDX) produces a high and durable complete response rate in patients with chemotherapy resistant T-cell lymphomas
    Meeting Abstract

    O'Connor, O. A.; Hamlin, P.; Moskowitz, C.; Portlock, C.; Sarasohn, D.; Dumitrescu, O.; Neylon, E.; Patterson, M.; Zelenetz, A.; Saunders, M.; more...
    Annals of Oncology (2008)

    Fulltext@MSK | Save
  • The T cell cytolytic molecules Fas ligand and TRAIL, the trafficking molecules CCR9, β7 integrin and PSGL-1, and the immune modulating molecules OX40, CEACAM1, and CTLA4 are required for thymic graft-versus-host disease
    Meeting Abstract

    Na, I. K.; Lu, S. X.; Goldberg, G. L.; Hirschhorn Cymerman, D. D.; King, C. G.; Smith, O. M.; Suh, D.; Rao, U.; Yim, N.; Holland, A. M.; more...
    Blood (2008)

    Fulltext@MSK | Save
  • Normalization of FDG-PET pre-ASCT with additional non-cross resistant chemotherapy improves EFS in patients with relapsed and primary refractory Hodgkin lymphoma - Memorial Sloan Kettering protocol 04-047
    Meeting Abstract

    Moskowitz, C. H.; Nimer, S. D.; Zelenetz, A. D.; Hamlin, P. A.; Horwitz, S. M.; Noy, A.; Portlock, C. S.; Straus, D. J.; Gerecitano, J.; Kewalramani, T.; more...
    Blood (2008)

    Fulltext@MSK | Save